AU2012216630B2 - Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators - Google Patents

Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators Download PDF

Info

Publication number
AU2012216630B2
AU2012216630B2 AU2012216630A AU2012216630A AU2012216630B2 AU 2012216630 B2 AU2012216630 B2 AU 2012216630B2 AU 2012216630 A AU2012216630 A AU 2012216630A AU 2012216630 A AU2012216630 A AU 2012216630A AU 2012216630 B2 AU2012216630 B2 AU 2012216630B2
Authority
AU
Australia
Prior art keywords
alkyl
substituted
halogen
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012216630A
Other versions
AU2012216630A1 (en
Inventor
Michael Ambuhl
Colleen Ruegger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/979,482 priority Critical
Priority to AU2008310846A priority patent/AU2008310846B2/en
Application filed by Novartis AG filed Critical Novartis AG
Priority to AU2012216630A priority patent/AU2012216630B2/en
Publication of AU2012216630A1 publication Critical patent/AU2012216630A1/en
Priority claimed from AU2013100558A external-priority patent/AU2013100558A4/en
Publication of AU2012216630B2 publication Critical patent/AU2012216630B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links